By Katherine Hartigan, VI Form
Mitochondrial Disease in C. elegans
Mitochondrial disease refers to a class of hundreds of disorders related to the mitochondria that are caused by mutations in either mitochondrial DNA (mtDNA) or nuclear DNA
(nDNA). These mutations disrupt cellular respiration and the production of ATP, resulting in the overproduction of damaging free radicals. Mitochondrial diseases were once thought to be rare, but links between mitochondrial defects and many diseases of aging have been discovered, making these diseases far more prevalent than previously thought. A cure is nonexistent, and treatments are often individualized or ineffective. Antioxidants, such as Coenzyme Q10, have the ability to neutralize free radicals, making them a logical choice as a dietary supplement for mitochondrial disease patients. In this experiment, the C. elegans mev-1 mutant was used as a model organism for human mitochondrial disease. MitoQ, a reengineered form of Coenzyme Q10 targeted to the mitochondria, was added as a supplement to the diet of mev-1 mutants. The groups of mev-1 mutants were observed and data was collected every 12 hours until their death to determine their approximate lifespan. Following experimentation and data collection, it was found that there was not a significant difference in between the lifespans of the control mev-1 mutants without MitoQ, and the experimental mev-1 mutants with the MitoQ added to their diet. It is necessary to repeat this experiment while collecting data in shorter time intervals than 12 hours in order to draw more accurate conclusions when completing future research.
Click here for FULL LAB REPORT
Katie Hartigan is a VI Form day student from Southborough, MA. She plays varsity lacrosse, is a STEM Fellow, and enjoys writing.